IMENVEO Trademark

Trademark Overview

On Friday, July 11, 2008, a trademark application was filed for IMENVEO with the United States Patent and Trademark Office. The USPTO has given the IMENVEO trademark a serial number of 79056395. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, July 11, 2018. This trademark is owned by NOVARTIS AG. The IMENVEO trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
imenveo

General Information

Serial Number79056395
Word MarkIMENVEO
Filing DateFriday, July 11, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, July 11, 2018
Registration Number3598773
Registration DateTuesday, March 31, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 13, 2009

Trademark Statements

Goods and ServicesVaccines for human use
Translation of Words in MarkThe wording "IMENVEO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 6, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxosmithkline Biologicals S.A.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressBE
Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type98 - Unknown
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCH-4002 Basel
CH

Trademark Events

Event DateEvent Description
Friday, February 8, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, February 8, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 14, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, July 6, 2016TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, July 6, 2016INVALIDATION PROCESSED
Wednesday, July 6, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 6, 2015CANCELLED SECTION 71
Friday, July 3, 2015CHANGE OF OWNER RECEIVED FROM IB
Sunday, April 28, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, October 10, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 20, 2009FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 20, 2009FINAL DISPOSITION PROCESSED
Thursday, July 9, 2009CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, July 1, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 31, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, March 26, 2009NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, January 13, 2009PUBLISHED FOR OPPOSITION
Wednesday, December 24, 2008NOTICE OF PUBLICATION
Friday, December 5, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 4, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 28, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 28, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 28, 2008ASSIGNED TO LIE
Monday, November 17, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 10, 2008REFUSAL PROCESSED BY IB
Wednesday, September 17, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 17, 2008REFUSAL PROCESSED BY MPU
Wednesday, September 17, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, September 16, 2008NON-FINAL ACTION WRITTEN
Monday, September 15, 2008ASSIGNED TO EXAMINER
Friday, August 22, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, August 21, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

imenveo human vaccines